Pacira BioSciences PCRX Cash Flow Statement (2010-2026)

NASDAQ PCRX
$36.38 +0.04 (+0.11%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Pacira BioSciences Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Pacira BioSciences reported cash from operations of $57.46M and free cash flow of $56.12M for the quarter ended Jun 2026, up 378.4% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
17.66M-5.13M6.83M19.88M-0.69M-10.10M-19.54M25.76M10.86M24.87M8.98M18.89M-143.47M16.04M4.81M-4.85M5.43M1.64M2.92M4.65M
Depreciation and DepletionDep. & Depletion
3.80M5.40M5.70M6.50M5.80M16.20M5.30M4.70M4.10M4.20M4.10M4.50M6.00M6.90M6.80M13.00M6.90M7.00M7.00M7.00M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
5.84M5.91M1.18M0.71M0.70M1.44M0.94M0.69M0.68M1.44M0.68M0.76M0.84M0.94M0.87M0.85M0.63M0.68M0.58M0.52M
Depreciation & Amortization (CF)Dep. & Amort.
5.73M13.07M20.03M20.86M20.20M30.41M19.60M19.05M18.43M18.49M18.43M18.86M20.25M21.24M21.17M27.32M21.19M21.34M21.33M21.30M
Share-based CompensationStock Comp.
10.78M10.89M11.19M11.54M12.68M12.68M11.99M10.96M12.53M12.42M13.15M12.52M13.23M12.27M14.55M15.47M13.98M13.50M13.54M14.96M
Deferred Taxes
5.34M-2.08M0.03M2.16M0.70M-10.84M-7.34M11.44M4.91M6.60M3.46M12.54M1.12M3.51M1.40M0.75M8.07M-3.74M1.73M3.91M
Gains from Sales and DivestituresGains Divest
-0.01M-0.18M
Gains from Investment SecuritiesGains Investment
1.03M-4.67M-0.07M-0.04M-0.52M-0.42M0.41M
Asset Writedowns and ImpairmentWritedown
16.13M163.20M0.04M
Other non-cash itemsOther Non-Cash
3.82M-1.07M-6.17M28.52M0.15M-3.73M-7.52M3.57M-8.59M-0.40M0.98M0.60M-2.30M1.70M
Change in Working Capital
Change in ReceivablesChange Receivables
-18.38M13.50M-4.22M-1.00M2.37M4.93M-5.19M5.88M-2.12M8.60M-3.92M3.14M-4.13M12.65M-8.56M9.61M0.90M8.80M1.57M10.51M
Change in InventoryChange Inventory
1.95M1.91M5.11M-3.07M-3.79M-0.74M-3.09M-0.85M4.39M7.83M-7.57M6.66M8.43M13.42M8.47M14.40M9.51M-4.82M-2.49M-5.96M
Change in Account PayablesChange Payables
-2.98M-9.44M6.11M-0.85M-0.58M1.59M2.63M7.06M-7.70M-1.07M-6.98M9.75M0.64M-0.33M2.46M6.88M-12.01M-2.93M-0.94M3.18M
Change in Accured ExpensesChange Accured Exp.
1.11M22.49M-9.16M-9.88M-4.52M3.70M-25.12M-5.65M4.62M4.55M3.47M-2.11M11.19M1.89M4.70M-19.38M7.53M14.00M-10.31M11.87M
Change in Other Operating AssetsOther Assets Change
-1.85M-0.24M4.26M-1.03M-2.67M2.13M1.93M2.44M2.62M-1.92M-0.90M2.21M5.03M-6.40M5.20M10.18M-1.47M-12.70M4.54M-4.92M
Change in Other Operating LiabilitiesOther Liabilities Change
-1.03M1.89M0.14M-1.18M0.42M-0.14M-0.24M0.39M-0.77M-0.02M-0.41M3.91M1.08M9.82M-5.83M3.29M1.07M
Other Working Capital ChangesOther WC Changes
0.82M2.13M-4.26M1.03M2.81M-3.31M-1.51M-2.59M-2.86M2.32M0.13M-2.23M-5.43M10.31M-4.12M-0.35M-4.36M12.70M-1.25M5.99M
Other Operating ActivitiesOther Ops.
0.04M-3.81M0.02M0.09M0.08M-0.18M-0.02M
Cash from OperationsCash from Ops.
60.29M23.22M30.78M29.81M42.65M42.04M19.13M43.50M44.44M47.58M49.10M53.24M53.92M33.13M35.46M12.01M60.83M43.69M25.68M57.46M
Investing Activities
Capital ExpendituresCapex
13.08M9.17M7.67M11.74M5.18M5.49M6.57M3.40M3.39M1.80M2.84M1.59M4.09M2.12M8.55M2.70M3.87M0.22M2.72M1.34M
Change in Property, Plant and EquipmentChange in PP&E
-13.08M-9.17M-7.67M-11.74M-5.18M-5.49M-6.57M-3.40M-3.39M-1.80M-2.84M-1.59M-4.09M-2.12M-8.55M-2.70M-3.87M-0.22M-2.72M-1.34M
Acquisitions
16.70M0.34M
Net of Acquisitions & DivestmentsNet Acquisitions
-16.70M-0.34M
Purchase of InvestmentsInvestments Purchased
198.33M98.00M168.35M32.04M132.04M68.26M53.50M22.77M42.17M25.93M56.06M49.73M101.24M45.20M69.63M6.31M38.77M27.59M3.91M
Sale and Maturity of InvestmentsInvestments Sold
176.33M598.12M62.94M89.70M84.94M126.25M33.50M41.23M36.10M43.36M36.10M53.17M46.95M69.25M71.17M86.25M47.14M22.50M17.00M
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-35.08M66.92M-208.02M19.16M-47.52M11.19M66.18M7.33M-4.34M8.37M-15.53M-15.22M-52.16M-0.37M-25.63M62.16M43.61M19.33M19.44M11.76M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
149.55M
Long-Term Debt RepaymentsLT Debt Repayment
9.38M9.38M59.38M296.88M2.81M27.81M2.81M2.81M196.82M2.81M3.75M195.92M
Non-Current Debt
-9.38M-9.38M-59.38M-296.88M-2.81M-27.81M146.74M-2.81M-196.82M-2.81M-3.75M-195.92M
Short-Term Debt issuancesST Debt Issuance
149.55M-149.55M
Short-Term Debt repaymentsST Debt Repayment
5.00M5.00M5.00M5.00M
Current Debt
149.55M-149.55M-5.00M-5.00M-5.00M-5.00M
Net Debt Issuances and RepaymentsNet Debt Issuance
-9.38M-9.38M-59.38M-147.33M-2.81M-27.81M-2.81M-2.81M-196.82M-2.81M-3.75M-200.92M-5.00M-5.00M-5.00M
Change in Capital Stock
Common Stock IssuedStock Issued
3.05M7.61M11.02M10.86M1.60M3.86M0.33M1.58M0.03M0.01M0.49M0.00M0.46M
Shares Repurchased
50.04M50.04M48.25M50.05M
Net Shares Issued and RepurchasedNet Shares Issued
3.05M7.61M11.02M10.86M1.60M3.86M0.33M1.58M0.03M-50.04M-50.03M-47.76M-50.04M0.46M
Net Equity Issued and RepurchasedNet Equity Issued
3.05M7.61M11.02M10.86M1.60M3.86M0.33M1.58M0.03M-50.04M-50.03M-47.76M-50.04M0.46M
Other financing activitiesOther financing
-8.37M-32.00M30.83M-6.91M-0.11M0.00M-36.44M-0.03M-0.08M-0.18M-5.29M-2.21M-0.13M-4.36M-4.83M
Cash from Financing ActivitiesCash from Financing
3.05M361.41M-181.59M-153.66M-7.78M-58.51M-153.91M0.44M-27.79M-1.78M-2.82M24.98M-2.85M-1.96M-2.99M-57.51M-257.48M-51.65M-59.40M-7.65M
Additional items
Exchange Rate EffectFX Effect
0.20M0.13M-0.41M0.04M
Change in Cash
28.26M451.54M-358.83M-104.69M-12.64M-5.29M-68.59M51.27M12.31M54.18M30.75M63.00M-1.09M30.81M6.84M16.87M-152.90M10.96M-14.24M61.57M
Ending Cash Balance
134.04M585.58M226.75M122.06M109.42M104.14M35.55M86.81M99.12M153.30M184.05M247.05M245.97M276.77M283.61M300.48M147.59M158.55M144.31M205.88M
Free Cash FlowFCF
47.21M14.05M23.11M18.07M37.47M36.55M12.56M40.10M41.04M45.79M46.27M51.65M49.83M31.01M26.91M9.32M56.96M43.47M22.96M56.12M
Net Cash FlowNCF
28.26M451.54M-358.83M-104.69M-12.64M-5.29M-68.59M51.27M12.31M54.18M30.75M63.00M-1.09M30.81M6.84M16.67M-153.03M11.37M-14.28M61.57M
Interest Paid
1.51M1.90M9.97M4.72M8.93M9.68M17.63M3.17M4.13M2.70M3.97M3.02M3.20M5.23M2.72M4.97M2.70M4.85M1.60M4.58M
Income Taxes PaidTaxes Paid
0.81M0.96M0.01M4.10M0.11M3.18M0.20M0.59M1.28M2.29M-0.25M4.91M4.91M1.45M0.29M7.95M0.71M0.05M0.86M

Pacira BioSciences Cash Flow Statement API

Pull Pacira BioSciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PCRX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY